Pharmacy Students' Ability to Identify Potential Drug-Drug Interactions

被引：11
|
作者：
Saverno, Kim R. [1 ]
Malone, Daniel C. [1 ]
Kurowsky, John [1 ]
机构：
[1] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
来源：
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION | 2009年 / 73卷 / 02期
关键词：
drug interaction; ALERTS; RECOGNITION; KNOWLEDGE; RISK;
D O I：
10.5688/aj730227
中图分类号：
G40 [教育学];
学科分类号：
040101 ; 120403 ;
摘要：
Objective. To evaluate the ability of third- and fourth-year pharmacy students to identify clinically significant drug-drug interactions (DDIs) Methods. A questionnaire designed to measure DDI knowledge was disseminated to fourth-year pharmacy students in a school of pharmacy. A second questionnaire was distributed to third- year pharmacy students in 2 schools of pharmacy (schools A and B) and re-administered to students in 1 of the schools 1 year later. Results. Class of 2005 fourth-year pharmacy students correctly categorized an average of 52% +/- 13% DDI pairs on the first questionnaire. Third-year pharmacy students at schools A and B correctly categorized an average of 61% +/- 18% and 66% +/- 15% of DDI pairs, respectively. The average percentage of correct responses for fourth-year students from the class of 2007 was 65% (+/- 17%). Conclusion. Pharmacy students' ability to identify important DDIs is far from optimal, even after completing experiential requirements.
引用
收藏
页数：8
相关论文
共 50 条
  • [41] Data mining for potential adverse drug-drug interactions
    Hammann, Felix
    Drewe, Juergen
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (05) : 665 - 671
  • [42] Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions
    Vazquez, Marta
    Garcia-Carnelli, Carlos
    Maldonado, Cecilia
    Fagiolino, Pietro
    CANNABINOIDS AND SLEEP: MOLECULAR, FUNCTIONAL AND CLINICAL ASPECTS, 2021, 1297 : 27 - 42
  • [43] Potential severe drug-drug interactions in elderly patients
    Reactions Weekly, 2021, 1879 (1) : 9 - 9
  • [44] Milnacipran Has Low Potential for Drug-Drug Interactions
    Periclou, Antonia
    Coutts, Stephen M.
    Rao, Sriniuas G.
    Palmer, Robert H.
    Thacker, Kim
    Trugman, Joel
    NEUROLOGY, 2009, 72 (11) : A212 - A212
  • [45] A Minimal Information Model for Potential Drug-Drug Interactions
    Hochheiser, Harry
    Jing, Xia
    Garcia, Elizabeth A.
    Ayvaz, Serkan
    Sahay, Ratnesh
    Dumontier, Michel
    Banda, Juan M.
    Beyan, Oya
    Brochhausen, Mathias
    Draper, Evan
    Habiel, Sam
    Hassanzadeh, Oktie
    Herrero-Zazo, Maria
    Hocum, Brian
    Horn, John
    LeBaron, Brian
    Malone, Daniel C.
    Nytro, Oystein
    Reese, Thomas
    Romagnoli, Katrina
    Schneider, Jodi
    Zhang, Louisa
    Boyce, Richard D.
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [46] The serotonin syndrome, triptans, and the potential for drug-drug interactions
    Shapiro, Robert E.
    Tepper, Stewart J.
    HEADACHE, 2007, 47 (02): : 266 - 269
  • [47] TERIFLUNOMIDE: POTENTIAL FOR TRANSPORTER MEDIATED DRUG-DRUG INTERACTIONS
    Weitz, D.
    Schmider, W.
    Menguy-Vacheron, F.
    Clot, P.
    Hermabessiere, S.
    Jiang, J.
    Su, Y.
    Thuillier, V.
    Turpault, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S112 - S113
  • [48] Cross-Sectional Assessment of Pharmacy Students' Knowledge and Perception of Drug-Drug Interactions with Over the Counter Products
    Abutaima, Rana
    Abufarha, Rana
    Thiab, Samar
    Alhamad, Hamza
    Albahar, Fares
    PHARMACY PRACTICE-GRANADA, 2023, 21 (04):
  • [49] DRUG-DRUG INTERACTIONS
    FORTH, W
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1976, 26 (NA1): : 108 - 114
  • [50] Drug-drug interactions
    Preskorn, SH
    JOURNAL OF CLINICAL PSYCHIATRY, 1996, 57 (05) : 223 - 225
12345